Objective
TP53 has been shown as a driver mutation in epithelial ovarian (EOC) and endometrial cancers (EC). We aim to compare biomarker profiles of tumor samples in relation to TP53 mutation to look for overlapping and different treatment paradigms.
– Caris Life Sciences
OBJECTIVE To evaluate ovarian clear cell carcinoma (OCCC) and endometrial clear cell carcinoma (ECCC) using multiplatform profiling technology and compare their molecular profiles to clear… […]
– Caris Life Sciences
Objectives: T-cell suppression via PD-1/PD-L1 interactions plays a central role in cancer progression and survival, making PD-1/PD-L1 attractive therapeutic targets. Clinical trials involving PD-1/PD-L1-targeted immunotherapies… […]
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
